Shionogi Reaches Endpoint for Phase 3 COVID-19 Pill
RBX2660 Could Heal Recurrent C Diff Patients, Physically and Psychologically
FDA Warns of Potential Monkeypox Transmission via FMT, Implements Additional Protections
Bivalent SARS-CoV-2 Vaccine Might Offer Better Omicron Protection
